Cellectis CLLS
NASDAQ CLLS
$1.38 +0.27 (+24.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Cellectis (CLLS) Other Non Operating Income (2021 - 2022)

Updated

Cellectis (CLLS) reported Other Non Operating Income of -$415,000 for Q4 2025, compared with -$562,000 a year earlier.

Analysis

Cellectis (CLLS) Other Non Operating Income (2021 - 2022) Analysis & Trends

For FY2025, Cellectis posted Other Non Operating Income of $339,000.

  • By year, Other Non Operating Income came in at -$308,000 in FY2024, $8,000 in FY2023, -$1.48 million in FY2022 and -$2.12 million in FY2021.
  • Five-year quarterly Other Non Operating Income spans a low of -$15.05 million in Q2 2021 and a high of $12.92 million in Q3 2021.
  • Per Business Quant data, the three quarters before Q4 2025 came in at -$283,000 (Q3 2025), $287,000 (Q2 2025) and $750,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cellectis 111.38 Mn -642.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 487,000.00
Mar 31, 2021 -1,000.00
API Access

Cellectis Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=CLLS&period=max&api_key=YOUR_API_KEY